Page last updated: 2024-10-26

dimaprit and Reperfusion Injury

dimaprit has been researched along with Reperfusion Injury in 2 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"The dimaprit treatment depressed the values to 40-64% of those in the corresponding control group 4-24 hr after reperfusion."1.35Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats. ( Adachi, N; Arai, T; Liu, K; Motoki, A; Nagaro, T; Nishibori, M; Takahashi, HK; Yorozuya, T, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, N2
Liu, K2
Motoki, A2
Nishibori, M2
Arai, T2
Takahashi, HK1
Yorozuya, T1
Nagaro, T1

Other Studies

2 other studies available for dimaprit and Reperfusion Injury

ArticleYear
Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats.
    European journal of pharmacology, 2006, Aug-21, Volume: 544, Issue:1-3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Clozapine; Dimaprit; Dose-Response Relat

2006
Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 102, Issue:4

    Topics: Adenosine Triphosphate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytokines; Dimap

2008